Press Release
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium
During meetings, management will discuss its commercial products, and data and other information shared during Akebia’s recent R&D Day that showcased its robust pipeline of clinical stage kidney disease programs.
About
Akebia Therapeutics Contact
mcarrasco@akebia.com
Source: Akebia Therapeutics, Inc.
Akebia Therapeutics
180 Third Ave, Floor 2
Waltham, MA 02452
+1 617.871.2098 phone
+1 617.871.2099 fax
